化疗致食管癌穿孔:支架置入后成功手术
本文报告一例73岁胸段食管癌患者在接受多西他赛、顺铂和5-氟尿嘧啶化疗第一周期第4天发生食管穿孔,经早期引流和食管支架置入控制感染后,完成第二周期化疗并接受食管次全切除术,最终实现完整切除。早期引流和支架置入对感染控制和后续完整切除至关重要。
要点
- 化疗期间出现食管穿孔需早期引流和支架置入控制感染。
- 感染控制后可继续化疗并择期行食管次全切除术。
- 早期干预是实现后续完整切除的关键。
核心结论
- 早期引流和支架置入对化疗所致食管穿孔的感染控制和后续完整切除至关重要。
研究设计与样本
- 个案报告:一例73岁胸段食管癌患者化疗期间发生食管穿孔。
主要发现
- 患者在第一周期多西他赛、顺铂和5-氟尿嘧啶化疗第4天发生食管穿孔。
- 置入食管支架并完成食管次全切除术后,给予第二周期化疗。
临床怎么用
- 化疗期间出现食管穿孔应早期引流并置入支架控制感染,为后续完整切除创造条件。
局限性
- 单个病例报告,结论推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Perforation of esophageal cancer solely due to preoperative chemotherapy is extremely rare, but can be associated with pyothorax and can be difficult to treat. Here, we report the case of a successfully treated patient with thoracic esophageal cancer who had esophageal perforation during docetaxel, cisplatin, and 5-fluorouracil chemotherapy. A 73-year-old patient had esophageal perforation on the fourth day of the first docetaxel, cisplatin, 5-fluorouracil cycle. The second docetaxel, cisplatin, 5-fluorouracil cycle was administered after insertion of esophageal stenting and subtotal esophagectomy. Early drainage and stent placement were crucial for achieving infection control and allowing for a subsequent complete resection.
引用
- Kobayashi T, Makino T, Yamasaki M, et al. Successful Stenting Followed by Surgery for Perforated Esophageal Cancer Due to Chemotherapy. Ann Thorac Surg. 2019. PMID: 31102633. doi:10.1016/j.athoracsur.2019.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。